#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic oesophagitis Liposarcoma recurrent Acute hepatic failure Langerhans cell sarcoma Factor VIII deficiency Fungal infection Pseudoxanthoma elasticum Cutaneous lupus erythematosus Cataract Pouchitis Uterine leiomyosarcoma Waldenstrom's macroglobulinaemia recurrent Carcinoid tumour Haemophilia B with anti factor IX Adenovirus infection More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Trials in Disease Hereditary hypophosphataemic rickets – Basic Information Hereditary neuropathic amyloidosis Aicardi-Goutieres syndrome – Trials in Disease Leiomyosarcoma recurrent – Basic Information Mantle cell lymphoma – Basic Information Usher’s syndrome – Life with Disease Hyperoxaluria – Life with Disease Alagille syndrome – Diagnostics CADASIL – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quetiapine Rugonersen At-1501 Davutamig Lysine Acetate Glepaglutide Idecabtagene Vicleucel Iobitridol Pc14586 Syn2 Clonazepam Cls12311 Thiopental Sodium Acp-017 Glutathione Brodalumab Posdinemab Potassium Canrenoate TROFOLASTAT Gsk3858279 More therapies…

    Learn about Your Condition

    VEXAS syndrome Type V hyperlipidaemia Aneurysm ruptured Anal fistula Acromegaly Lennox-Gastaut syndrome Craniosynostosis Cystic fibrosis Brain neoplasm Castleman's disease Colonoscopy Latent tuberculosis Liposarcoma Exposure via breast milk Precocious puberty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myelodysplastic syndrome

  • Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Allogenic stem cell transplantation
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    Germany

  • Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

    Recruiting

    3 1
    Investigated Drugs:
    • Elritercept
    Bulgaria Czechia France Germany Hungary Ireland +5

  • Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Melphalan
    • Treosulfan
    • Fludarabine
    Germany

  • Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    Italy

  • Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Ivosidenib
    France Germany Italy The Netherlands Spain

  • Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Ion440
    Austria France Spain
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!